Although further studies (including analysis of larger patient groups) are warranted to fully dissect the complex molecular events underlying action/regulation of heparanase in modulating effects of metabolic disorders on breast cancer progression, our findings point to the importance of the interplay between enzymatic activity of heparanase and insulin signaling in facilitating breast tumorigenesis. Here, HPSE is linked to breast cancer.